31/01/2026
UK TMS in the news
Transcranial Magnetic Stimulation (TMS) is gaining national attention as a low-cost, evidence-based lifeline for people living with moderate to severe treatment-resistant depression.
A new feature published by Medical Xpress highlights findings from the BRIGHTMIND study, which evaluated the economic and clinical impact of TMS for depression in the UK. The study, published in the BMJ, makes a compelling case for wider investment in neurostimulation within mental health services.
The research utilised Magstim Horizon Performance technology with a navigated TMS package, reinforcing the growing role of precision neuromodulation in modern psychiatric care.
Huge credit to Edward Cox, Jing Ma, Christina Roadevin, Richard Morriss, Marilyn James, and the wider BRIGHTMIND study team for advancing accessible, effective mental health treatment.
🔗 Read the article here:
https://medicalxpress.com/news/2026-01-magnetic-pulses-brain-emerge-lifeline.html